rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gerald W. McLaughlin

Director

Company insider

Files Form 4 as: Director, Allarity Therapeutics; Director, Aytu BioPharma; Chief Executive Officer, Neos Therapeutics; Director, Skye Bioscience; SVP, Chief Commercial Officer, Nupathe.

Every Form 4 they filed

In numbers

Trades disclosed
38
Buys
2
Sells
0
Bought
$51K
Sold
$0
Companies
5
Companies where not an officer
3
First trade
8 Mar 2012
Last trade
28 Jan 2026
Last filed
7 May 2026

Companies traded

Where they are an officer
Neos TherapeuticsDirector, Officer · last 19 Mar 20212 buys · 0 sells
NupatheOfficer · last 21 Feb 20140 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ALLR Allarity TherapeuticsDirector · Biotechnology · last 28 Jan 20260 buys · 0 sells
AYTU Aytu BioPharmaDirector · Biotechnology · last 8 Apr 20210 buys · 0 sells
SKYE Skye BioscienceDirector · Biotechnology · last 20 Oct 20150 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
28 Jan 2026filed 7 May 2026ALLR Allarity TherapeuticsBiotechnologySEC FORM 4 Code A—45,000 at $0.00filing
28 Jan 2026filed 7 May 2026ALLR Allarity TherapeuticsBiotechnologySEC FORM 4 Code A—45,000 at $0.00filing
22 Jan 2025filed 24 Jan 2025ALLR Allarity Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
22 Jan 2025filed 24 Jan 2025ALLR Allarity Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
8 Apr 2021filed 12 Apr 2021AYTU Aytu BioPharmaBiotechnologySEC FORM 4 Code A—6,500 at $0.00filing
19 Mar 2021filed 19 Mar 2021Neos Therapeuticsoption or derivativeSEC FORM 4 Code D—600,000 at $0.00filing
19 Mar 2021filed 19 Mar 2021Neos Therapeuticsoption or derivativeSEC FORM 4 Code D—392,688 at $0.00filing
19 Mar 2021filed 19 Mar 2021Neos Therapeuticsoption or derivativeSEC FORM 4 Code D—395,000 at $0.00filing
19 Mar 2021filed 19 Mar 2021Neos Therapeuticsoption or derivativeSEC FORM 4 Code D—100,000 at $0.00filing
19 Mar 2021filed 19 Mar 2021Neos Therapeuticsoption or derivativeSEC FORM 4 Code D—65,447 at $0.00filing
19 Mar 2021filed 19 Mar 2021Neos TherapeuticsSEC FORM 4 Code D—270,171filing
2 Mar 2021filed 16 Mar 2021Neos TherapeuticsSEC FORM 4 Code F$37K44,329 at $0.84filing
13 Mar 2020filed 16 Mar 2020Neos Therapeuticsoption or derivativeSEC FORM 4 Code A—100,000 at $0.00filing
13 Mar 2020filed 16 Mar 2020Neos Therapeuticsoption or derivativeSEC FORM 4 Code A—65,447 at $0.00filing
2 Mar 2020filed 4 Mar 2020Neos Therapeuticsoption or derivativeSEC FORM 4 Code A—395,000 at $0.00filing
2 Mar 2020filed 4 Mar 2020Neos TherapeuticsSEC FORM 4 Code A—290,000 at $0.00filing
1 Mar 2019filed 22 Mar 2019Neos Therapeuticsoption or derivativeSEC FORM 4 Code A—392,688 at $0.00filing
1 Mar 2019filed 4 Mar 2019Neos Therapeuticsoption or derivativeSEC FORM 4 Code A—523,583 at $0.00filing
6 Dec 2018filed 10 Dec 2018Neos TherapeuticsSEC FORM 4 Bought$36K17,097 at $2.11filing
4 Dec 2018filed 7 Dec 2018Neos TherapeuticsSEC FORM 4 Bought$15K7,403 at $2.04filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.